Condition: Sickle Cell Disease · Measles Vaccination · Sickle Cell Anemia · Sponsor: Children's Hospital Medical Center, Cincinnati
The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)
This description comes directly from the study's public registry record.
Teresa Latham · 513-803-7922 · Teresa.Latham@cchmc.org
Amy Shova · (513) 803-1917 · Amy.Shova@cchmc.org
Always discuss trial participation with your own doctor first.
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Korle Bu Teaching Hospital | Accra, Ghana, Ghana | Recruiting |
| Bugando Medical Centre | Mwanza, Tanzania | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356050